[Federal Register Volume 79, Number 111 (Tuesday, June 10, 2014)]
[Notices]
[Pages 33194-33195]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-13397]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-14-0896]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Community-based Organization (CBO) Monitoring and Evaluation
Project (CMEP) of WILLOW (CMEP-WILLOW) (OMB No. 0920-0896, expires 8/
31/2014)--Extension--National Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
CDC began formally partnering with CBOs in the late 1980s to expand
the reach of HIV prevention efforts. CBOs were, and continue to be,
recognized as important partners in HIV prevention because of their
history and credibility with target populations and their access to
groups that may not be easily reached. Over time, CDC's program for HIV
prevention by CBOs has grown in size, scope, and complexity to respond
to changes in the epidemic, including the diffusion and implementation
of Effective Behavioral Interventions (EBIs) for HIV prevention. Women
Involved in Life Learning from Other Women (WILLOW) is an EBI that
focuses on health education and social skills building among women
living with HIV.
CDC's EBIs have been shown to be effective under controlled
research environments, but there is limited data on intervention
implementation and client outcomes in real-world settings (as
implemented by CDC-funded CBOs). The purpose of CMEP is to improve the
performance of CDC-funded CBOs delivering particular individual- or
group-level behavioral interventions. This is done by monitoring
changes in clients' self-reported HIV transmission risk behaviors after
participating in the intervention.
CDC funded four (4) CBOs to participate in CMEP-WILLOW for five (5)
years (September 2010-August 2015). From October 1, 2011 through March
21, 2014, baseline surveys were conducted with 941 participants; 90-day
follow up surveys were completed with 700 participants, and 180-day
follow up surveys were completed with 609 participants.
CDC is requesting additional time to complete follow up surveys at
90- and 180-days for participants completing the intervention on or
before 8/31/2014. Following their participation in the WILLOW
intervention, participants will complete an 18 minute, self-
administered, computer based interview at two follow-up time points
(90- and 180-days following the WILLOW intervention) to assess their
HIV-related attitudes and behavioral risks. CBOs will be expected to
retain 80% of these participants at both follow-up interviews. CBO
agency staff will submit data files to CDC monthly. It is estimated it
will take 5 minutes to upload to the CDC's Secure Data Network (SDN).
Throughout the project, funded CBOs will be responsible for
managing the daily procedures of CMEP-WILLOW to ensure that all
required activities are performed, all deadlines are met, and quality
assurance plans, policies and procedures are upheld. CBOs will be
responsible for participating in all CDC-sponsored grantee meetings
related to CMEP-WILLOW. The total estimated annual burden hours are
200.
[[Page 33195]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Avg. burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hrs.)
----------------------------------------------------------------------------------------------------------------
General population.................... 90-day Follow-up Survey. 320 1 18/60
CMEP-WILLOW grantees.................. 90-day SDN Submission... 4 12 5/60
General population.................... 180-day Follow-up Survey 320 1 18/60
CMEP-WILLOW grantees.................. 180-day SDN Submission.. 4 12 5/60
----------------------------------------------------------------------------------------------------------------
Leroy Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2014-13397 Filed 6-9-14; 8:45 am]
BILLING CODE 4163-18-P